DK3609898T3 - Forbindelser, der er nyttige som ret-hæmmere - Google Patents
Forbindelser, der er nyttige som ret-hæmmere Download PDFInfo
- Publication number
- DK3609898T3 DK3609898T3 DK18719276.0T DK18719276T DK3609898T3 DK 3609898 T3 DK3609898 T3 DK 3609898T3 DK 18719276 T DK18719276 T DK 18719276T DK 3609898 T3 DK3609898 T3 DK 3609898T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds useful
- ret inhibitors
- ret
- inhibitors
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1705971.8A GB201705971D0 (en) | 2017-04-13 | 2017-04-13 | Inhibitor compounds |
| PCT/GB2018/050986 WO2018189553A1 (en) | 2017-04-13 | 2018-04-13 | Compounds useful as ret inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3609898T3 true DK3609898T3 (da) | 2022-09-05 |
Family
ID=58744532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18719276.0T DK3609898T3 (da) | 2017-04-13 | 2018-04-13 | Forbindelser, der er nyttige som ret-hæmmere |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US11352361B2 (da) |
| EP (2) | EP3609898B1 (da) |
| JP (2) | JP7277376B2 (da) |
| CN (2) | CN115785100A (da) |
| AU (3) | AU2018252251B2 (da) |
| BR (1) | BR112019021231A2 (da) |
| CA (1) | CA3059134A1 (da) |
| DK (1) | DK3609898T3 (da) |
| ES (1) | ES2925077T3 (da) |
| GB (1) | GB201705971D0 (da) |
| HR (1) | HRP20221040T1 (da) |
| HU (1) | HUE059716T2 (da) |
| LT (1) | LT3609898T (da) |
| PL (1) | PL3609898T3 (da) |
| PT (1) | PT3609898T (da) |
| RS (1) | RS63514B1 (da) |
| RU (1) | RU2760669C2 (da) |
| SI (1) | SI3609898T1 (da) |
| WO (1) | WO2018189553A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE064659T2 (hu) | 2015-11-02 | 2024-04-28 | Blueprint Medicines Corp | RET inhibitorai |
| GB201705971D0 (en) * | 2017-04-13 | 2017-05-31 | Cancer Res Tech Ltd | Inhibitor compounds |
| EP3740490A1 (en) * | 2018-01-18 | 2020-11-25 | Array Biopharma, Inc. | Substituted pyrazolo[3,4-d]pyrimidine compounds as ret kinase inhibitors |
| CN111615514B (zh) | 2018-01-18 | 2022-10-11 | 奥瑞生物药品公司 | 作为ret激酶抑制剂的取代的吡唑并[4,3-c]吡啶化合物 |
| EP3740491A1 (en) | 2018-01-18 | 2020-11-25 | Array Biopharma, Inc. | Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors |
| EP4353317A3 (en) | 2018-04-03 | 2024-05-08 | Blueprint Medicines Corporation | Ret inhibitor for use in treating cancer having a ret alteration |
| EP3833372A4 (en) | 2018-08-10 | 2022-06-08 | Blueprint Medicines Corporation | TREATMENT OF EGFR MUTANT CANCER |
| WO2020094084A1 (zh) * | 2018-11-07 | 2020-05-14 | 南京明德新药研发有限公司 | 作为ret抑制剂的三并环衍生物 |
| CN111454268B (zh) * | 2019-01-18 | 2023-09-08 | 明慧医药（上海）有限公司 | 作为布鲁顿酪氨酸激酶抑制剂的环状分子 |
| EP3950685A4 (en) * | 2019-04-03 | 2022-12-14 | Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory | PYRAZOLOPYRIDINE COMPOUND USED AS RET INHIBITOR AND USES THEREOF |
| CN113214294A (zh) * | 2020-06-10 | 2021-08-06 | 深圳铂立健医药有限公司 | 三环化合物、药物组合物及其应用 |
| EP4194455A4 (en) * | 2020-09-29 | 2024-04-03 | Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory | CRYSTALLINE FORMS OF PYRIDOPYRAZOLE COMPOUNDS AND PRODUCTION PROCESSES THEREOF |
| EP4370207A1 (en) | 2021-07-12 | 2024-05-22 | Nido Biosciences, Inc. | Bicyclic compounds as androgen receptor modulators |
| EP4415718A1 (en) * | 2021-10-15 | 2024-08-21 | Stemline Therapeutics Inc. | Inhibitors of mutant ret kinases for use in treating cancer |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0322779A3 (en) | 1987-12-29 | 1991-05-08 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzolactam compounds and pharmaceutical uses thereof |
| US5480883A (en) | 1991-05-10 | 1996-01-02 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| ES2194181T3 (es) | 1996-02-13 | 2003-11-16 | Astrazeneca Ab | Derivados de quinazolina como inhibidores de vegf. |
| CA2244897C (en) | 1996-03-05 | 2006-04-11 | Zeneca Limited | 4-anilinoquinazoline derivatives |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| SI1553097T1 (sl) | 1999-02-10 | 2010-12-31 | Astrazeneca Ab | Kinazolinski derivati kot inhibitorji angiogeneze in intermediati za to |
| AU2001258628A1 (en) | 2000-05-31 | 2001-12-11 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| UA73993C2 (uk) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
| WO2002008213A1 (en) | 2000-07-07 | 2002-01-31 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as angiogenesis inhibitors |
| AU6623301A (en) | 2000-07-07 | 2002-01-21 | Angiogene Pharm Ltd | Colchinol derivatives as vascular damaging agents |
| US7119200B2 (en) | 2002-09-04 | 2006-10-10 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| US7429596B2 (en) | 2003-06-20 | 2008-09-30 | The Regents Of The University Of California | 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof |
| JP2008520744A (ja) | 2004-11-19 | 2008-06-19 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 抗炎症性ピラゾロピリミジン |
| WO2006092430A1 (de) | 2005-03-03 | 2006-09-08 | Universität des Saarlandes | Selektive hemmstoffe humaner corticoidsynthasen |
| DK1951724T3 (da) | 2005-11-17 | 2011-08-15 | Osi Pharmaceuticals Llc | Sammensmeltede bicykliske mTOR-inhibitorer |
| AR057960A1 (es) | 2005-12-02 | 2007-12-26 | Osi Pharm Inc | Inhibidores de proteina quinasa biciclicos |
| WO2007075554A2 (en) * | 2005-12-19 | 2007-07-05 | Osi Pharmaceuticals, Inc. | Combination of igfr inhibitor and anti-cancer agent |
| CN101389630A (zh) | 2005-12-29 | 2009-03-18 | 艾博特公司 | 蛋白激酶抑制剂 |
| GB0610242D0 (en) | 2006-05-23 | 2006-07-05 | Novartis Ag | Organic compounds |
| JP2008063278A (ja) | 2006-09-07 | 2008-03-21 | Fujifilm Finechemicals Co Ltd | １−ピリジン−４−イル−インドール類の製造方法 |
| SI2529622T1 (en) | 2006-09-22 | 2018-06-29 | Pharmacyclics Llc | Bruton tyrosine kinase inhibitors |
| WO2009008992A2 (en) | 2007-07-06 | 2009-01-15 | Osi Pharmaceuticals Inc. | Combination anti-cancer therapy comprising an inhibitor of both mtorc1 and mt0rc2 |
| RU2513636C2 (ru) * | 2008-01-04 | 2014-04-20 | Интелликайн ЭлЭлСи | Некоторые химические структуры, композиции и способы |
| US8193182B2 (en) * | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
| BRPI0906474A2 (pt) | 2008-01-04 | 2015-07-14 | Intellikine Inc | Certas entidades químicas, composições e métodos |
| US9096611B2 (en) | 2008-07-08 | 2015-08-04 | Intellikine Llc | Kinase inhibitors and methods of use |
| WO2010006072A2 (en) | 2008-07-08 | 2010-01-14 | The Regents Of The University Of California | Mtor modulators and uses thereof |
| CA2738429C (en) * | 2008-09-26 | 2016-10-25 | Intellikine, Inc. | Heterocyclic kinase inhibitors |
| US8476282B2 (en) * | 2008-11-03 | 2013-07-02 | Intellikine Llc | Benzoxazole kinase inhibitors and methods of use |
| US20110269779A1 (en) | 2008-11-18 | 2011-11-03 | Intellikine, Inc. | Methods and compositions for treatment of ophthalmic conditions |
| KR101061599B1 (ko) | 2008-12-05 | 2011-09-02 | 한국과학기술연구원 | 비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물 |
| EA036876B1 (ru) * | 2009-11-05 | 2020-12-30 | Ризен Фармасьютикалз С.А. | Ингибиторы pi3k киназы |
| US9765037B2 (en) | 2010-01-28 | 2017-09-19 | University Of Washington Through Its Center For Commercialization | Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases |
| EP2528919B1 (en) | 2010-01-28 | 2016-11-02 | University of Washington | Compositions and methods for treating toxoplasmosis. cryptosporidiosis and other apicomplexan protozoan related diseases |
| WO2011153553A2 (en) | 2010-06-04 | 2011-12-08 | The Regents Of The University Of California | Methods and compositions for kinase inhibition |
| US20110304649A1 (en) * | 2010-06-10 | 2011-12-15 | Microsoft Corporation | Character selection |
| US20130296316A1 (en) | 2010-07-09 | 2013-11-07 | Michael P. Pollastri | Antiparasitic Agents Based On mTOR Inhibitors |
| CN106619647A (zh) | 2011-02-23 | 2017-05-10 | 因特利凯有限责任公司 | 激酶抑制剂的组合及其用途 |
| JP6047149B2 (ja) | 2011-05-04 | 2016-12-21 | インテリカイン， エルエルシー | 併用の医薬組成物およびその使用 |
| JP2014521725A (ja) | 2011-08-10 | 2014-08-28 | ノバルティス・ファルマ・アクチェンゲゼルシャフト | ＪＡＫＰＩ３Ｋ／ｍＴＯＲ併用療法 |
| AU2012341028C1 (en) | 2011-09-02 | 2017-10-19 | Mount Sinai School Of Medicine | Substituted pyrazolo[3,4-D]pyrimidines and uses thereof |
| WO2013070976A1 (en) | 2011-11-08 | 2013-05-16 | Intellikine, Llc | Treatment regimens using multiple pharmaceutical agents |
| US20130209543A1 (en) | 2011-11-23 | 2013-08-15 | Intellikine Llc | Enhanced treatment regimens using mtor inhibitors |
| US8501724B1 (en) | 2012-01-31 | 2013-08-06 | Pharmacyclics, Inc. | Purinone compounds as kinase inhibitors |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| US9738610B2 (en) | 2012-09-24 | 2017-08-22 | Whitehead Institute For Biomedical Research | Indazole derivatives and uses thereof |
| GB201217285D0 (en) | 2012-09-27 | 2012-11-14 | Univ Central Lancashire | Indole derivatives |
| CN105246482A (zh) | 2013-03-15 | 2016-01-13 | 因特利凯有限责任公司 | 激酶抑制剂的组合及其用途 |
| WO2014153509A1 (en) | 2013-03-22 | 2014-09-25 | Millennium Pharmaceuticals, Inc. | Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase |
| EP2997030B1 (en) * | 2013-05-14 | 2017-08-09 | Nerviano Medical Sciences S.R.L. | Pyrrolo[2,3-d]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
| US20160272645A1 (en) | 2013-10-18 | 2016-09-22 | Medivation Technologies, Inc. | Heterocyclic Compounds and Methods of Use |
| US20210317140A1 (en) | 2013-10-18 | 2021-10-14 | Medivation Technologies, Inc. | Heterocyclic Compounds and Methods of Use |
| GB201321146D0 (en) | 2013-11-29 | 2014-01-15 | Cancer Rec Tech Ltd | Quinazoline compounds |
| US10221181B2 (en) * | 2014-11-14 | 2019-03-05 | Nerviano Medical Sciences S.R.L. | 6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors |
| CA2974702C (en) | 2015-01-26 | 2023-10-10 | University Of Washington | Compositions and methods for treating toxoplasmosis, cryptosporidiosis and other apicomplexan protozoan related diseases |
| KR101766194B1 (ko) * | 2015-08-07 | 2017-08-10 | 한국과학기술연구원 | RET 키나아제 저해제인 신규 3-(이속사졸-3-일)-피라졸로[3,4-d]피리미딘-4-아민 화합물 |
| WO2017027883A1 (en) | 2015-08-13 | 2017-02-16 | San Diego State University Research Foundation | Atropisomerism for increased kinase inhibitor selectivity |
| TW201722958A (zh) * | 2015-09-15 | 2017-07-01 | 葛蘭素史克智慧財產（第二）有限公司 | 化學化合物 |
| WO2017160717A2 (en) | 2016-03-15 | 2017-09-21 | Memorial Sloan Kettering Cancer Center | Method of treating diseases using kinase modulators |
| RU2742115C2 (ru) | 2016-04-15 | 2021-02-02 | Кэнсер Рисерч Текнолоджи Лимитед | Гетероциклические соединения в качестве ингибиторов киназы RET |
| US10844067B2 (en) | 2016-04-15 | 2020-11-24 | Cancer Research Technology Limited | Heterocyclic compounds as RET kinase inhibitors |
| GB201705971D0 (en) * | 2017-04-13 | 2017-05-31 | Cancer Res Tech Ltd | Inhibitor compounds |
-
2017
- 2017-04-13 GB GBGB1705971.8A patent/GB201705971D0/en not_active Ceased
-
2018
- 2018-04-13 JP JP2019555675A patent/JP7277376B2/ja active Active
- 2018-04-13 ES ES18719276T patent/ES2925077T3/es active Active
- 2018-04-13 RS RS20220789A patent/RS63514B1/sr unknown
- 2018-04-13 RU RU2019132155A patent/RU2760669C2/ru active
- 2018-04-13 WO PCT/GB2018/050986 patent/WO2018189553A1/en unknown
- 2018-04-13 PT PT187192760T patent/PT3609898T/pt unknown
- 2018-04-13 HR HRP20221040TT patent/HRP20221040T1/hr unknown
- 2018-04-13 CA CA3059134A patent/CA3059134A1/en active Pending
- 2018-04-13 EP EP18719276.0A patent/EP3609898B1/en active Active
- 2018-04-13 US US16/604,332 patent/US11352361B2/en active Active
- 2018-04-13 SI SI201830743T patent/SI3609898T1/sl unknown
- 2018-04-13 EP EP22175240.5A patent/EP4105219A1/en active Pending
- 2018-04-13 AU AU2018252251A patent/AU2018252251B2/en active Active
- 2018-04-13 CN CN202211253646.1A patent/CN115785100A/zh active Pending
- 2018-04-13 LT LTEPPCT/GB2018/050986T patent/LT3609898T/lt unknown
- 2018-04-13 DK DK18719276.0T patent/DK3609898T3/da active
- 2018-04-13 CN CN201880024433.7A patent/CN110506043B/zh active Active
- 2018-04-13 HU HUE18719276A patent/HUE059716T2/hu unknown
- 2018-04-13 PL PL18719276.0T patent/PL3609898T3/pl unknown
- 2018-04-13 BR BR112019021231A patent/BR112019021231A2/pt active Search and Examination
-
2022
- 2022-04-07 AU AU2022202325A patent/AU2022202325B2/en active Active
- 2022-05-06 US US17/738,278 patent/US11680068B2/en active Active
-
2023
- 2023-05-04 US US18/312,069 patent/US20240132504A1/en not_active Abandoned
- 2023-05-08 JP JP2023076767A patent/JP7536949B2/ja active Active
-
2024
- 2024-08-22 AU AU2024213175A patent/AU2024213175A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3609898T3 (da) | Forbindelser, der er nyttige som ret-hæmmere | |
| FR24C1016I1 (fr) | Inhibiteurs de ret | |
| DK3873903T3 (da) | Substituerede 6-azabenzimidazolforbindelser som hpk1-hæmmere | |
| DK3582780T3 (da) | Aminopyrimidinforbindelser, der er anvendelige som SSAO-inhibitorer | |
| DK3442980T3 (da) | Heterocykliske forbindelser som ret-kinase-hæmmere | |
| DK3697785T3 (da) | Imidazo-pyridine forbindelser som pad-inhibitorer | |
| DK3684767T3 (da) | Heterocykliske forbindelser som pad-inhibitorer | |
| DK3461821T3 (da) | Indolcarboxamidforbindelser, der er brugbar som kinasehæmmere | |
| DK3656769T3 (da) | Aryl-phosphor-oxygen-forbindelse som egfr-kinase-inhibitor | |
| DK3371190T3 (da) | Heterocykliske forbindelser som pi3k-gamma-inhibitorer | |
| DK3472167T3 (da) | Heterocykliske forbindelser som immunomodulatorer | |
| DK3377488T3 (da) | Heterocykliske forbindelser som immunomodulatorer | |
| DK3768674T3 (da) | Aminopyrimidinderivater som ctps1-hæmmere | |
| DK3704120T3 (da) | Heterocykliske forbindelser som prmt5-inhibitorer | |
| DK3728252T3 (da) | 4-azaindolforbindelser | |
| DK3277677T3 (da) | 1-cyano-pyrrolidinforbindelser som usp30-hæmmere | |
| DK3390395T3 (da) | Forbindelser, der kan anvendes som kinase-inhibitorer | |
| DK3230278T3 (da) | Hidtil ukendte methyl-piperidin-forbindelser, som er anvendelige til inhibering af mikrosomale prostaglandin-e2-syntase-1 | |
| DK3442535T3 (da) | Heterocykliske stoffer som as ret-kinase-hæmmere | |
| DK3235819T3 (da) | Pyrrolopyrimidinforbindelser, der er anvendelige som JAK-inhibitorer | |
| DK3313832T3 (da) | 3-tetrazolyl-benzen-1,2-disulfonamidderivater som metallo-beta- lactamase-hæmmere | |
| DK3294713T5 (da) | Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer | |
| DK3003038T3 (da) | 2h-1,2,3-triazolderivater som inhibitorer af fibrose | |
| DK3552017T3 (da) | Forbindelser, der er anvendelige som ripk1-inhibitorer | |
| DK3544981T3 (da) | Benzodiazoliumforbindelser som enac-inhibitorer |